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The intestinal microbiota is believed to play a role in the pathogenesis of inflammatory 
bowel disease in humans and chronic inflammatory enteropathy (CIE) in dogs. While 
most of the previous studies have described the gut microbiota using sequencing 
methods, it is fundamental to assess the spatial distribution of the bacteria for a better 
understanding of their relationship with the host. The microbiota in the colonic mucosa 
of 22 dogs with CIE and 11 control dogs was investigated using fluorescence in situ 
hybridization (FISH) with a universal eubacterial probe (EUB338) and specific probes 
for select bacterial groups. The number of total bacteria labeled with EUB338 probe was 
lower within the colonic crypts of dogs with CIE compared to controls. Helicobacter spp. 
and Akkermansia spp. were decreased on the colonic surface and in the crypts of dogs 
with CIE. Dogs with CIE had increased number of Escherichia coli/Shigella spp. on the 
colonic surface and within the crypts compared to control dogs. In conclusion, the 
bacterial microbiota in the colonic mucosa differed between dogs with and without CIE, 
with depletion of the crypt bacteria in dogs with CIE. The crypt bacterial species that 
was intimately associated with the host mucosa in control dogs was composed mainly 
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 The gut microbiota in humans and animals is host-specific but diverse, with 
variations along the longitudinal axis of the intestine.17,23,50 The luminal microbiota is 
associated with the digesta and encompasses the majority of the bacteria in the gut.54 In 
the small intestine, the microbiota is predominated by facultative anaerobes19 that can 
tolerate the acidic environment that contains oxygen and antimicrobial molecules such 
as bile acids. The bacterial density increases in the cecum and colon with the most 
diverse and dense bacterial communities within the body, especially composed of strict 
anaerobes.19,30 This higher abundance of bacteria in the lumen of the large intestine is 
explained by the slower transit, presence of fermentable polysaccharides, and 
decreased concentration of antimicrobial substances.18,54  
 Besides the variation in distribution of facultative anaerobes and strict anaerobes 
along the intestinal segments, the intestinal compartments (e.g., lumen, mucus layer 
and crypts) also show a distinct bacterial composition, considered as niches.16 The 
bacteria associated with the mucus on the mucosal surface and crypts can be defined 
as the mucosal microbiota. The spatial organization of microorganisms is dependent on 
the metabolism of the bacteria and the host, the folding of the mucosa in the large 
intestine, and the organization of the mucus .7,33 Some organisms are able to penetrate 
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the mucus and colonize the colonic crypts, maintaining direct contact with the host 
epithelium.12,37 The environment closer to the epithelium has a higher oxygen level that 
selects for facultative aerobic taxa such as Proteobacteria and Actinobacteria.1 A clear 
differentiation between luminal and mucosa-associated communities has been reported 
in several species, including humans,17,62 mice,57 pigs,8 cattle,28 and primates.61  
 Humans with inflammatory bowel disease and dogs with chronic inflammatory 
enteropathy (CIE) have been shown to have both fecal and intestinal dysbiosis.20,31,55 
Similar to inflammatory bowel disease in humans, the cause of canine CIE is likely a 
combination of genetic predisposition, environmental factors and alterations in the 
intestinal microbiota that together induce an aberrant immune response in the host.59 In 
dogs with CIE, the fecal microbial changes comprise increased abundance of the 
Proteobacteria, especially Enterobacteriaceae, and decreased representation of the 
Firmicutes, including Faecalibacterium, Blautia, Turicibacter, and Clostridium cluster 
XIV species.31 Metagenomic sequencing methods are widely used to characterize the 
intestinal microbiota in dogs.31,51 These tools generate information about the relative 
abundance of bacterial taxa present in the feces and intestinal lumen. In order to study 
the bacterial populations in situ, it is crucial to utilize techniques such as fluorescence in 
situ hybridization (FISH) that preserve the mucosal biofilm, thereby providing an 
opportunity for spatial analysis of bacterial load and diversity.5 Few studies have 
investigated the in situ microbiota in dogs with CIE.9,60 Cassmann et al. described the 
mucosal bacteria in the ileum and colon of dogs with CIE, reporting increases in 
bacteria belonging to the Clostridium coccoides/Eubacterium rectale group, Bacteroides 
spp., Enterobacteriaceae, and E. coli compared to control dogs.9 The objective of this 
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study was to characterize and describe the bacteria in the colonic mucosa of control 
dogs and dogs with CIE using FISH to target bacterial groups that have been 
demonstrated to be altered in dogs with CIE and human patients with inflammatory 
bowel disease. Additionally, we investigated a possible correlation between the 
localization and number of bacteria with the canine inflammatory bowel disease activity 
index (CIBDAI) and severity of colonic histological lesions.  
 
Material and methods  
Ethics Statement  
The collection and analysis of samples from dogs with CIE was approved by the 
Texas A&M University Institutional Animal Care and Use Committee (Animal use 
protocols 2012-083 and 2015-0069) or by the Finnish National Animal Experiment 
Board (ESAVI/6973/04.10.03/2011 and ESAVI/10384/04.10.07/2014), for dogs enrolled 
at Texas A&M University or the University of Helsinki, respectively. Written consent was 
obtained from all owners of dogs. Dogs in the control group were euthanized for 
reasons unrelated to this study and the bodies were donated for teaching and research 
purposes. The post-euthanasia collection of samples was exempted by the Texas A&M 
University Institutional Animal Care and Use Committee.  
 
Animal Population and Samples 
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The control group comprised 11 adult dogs without a history of gastrointestinal 
disease. The dogs presented to the Texas A&M Veterinary Teaching Hospital with 
traumatic injuries and were euthanized at the owner’s request. None of the dogs had 
received antibiotics or immunomodulatory therapy in the preceding 6 months. Full-
thickness samples from the gastrointestinal tract, including the ascending, transverse, 
and distal colon, were collected within 20 minutes of euthanasia, fixed in 10% formalin, 
routinely processed for histopathology, and stained with hematoxylin and eosin. None of 
the control dogs had significant gross or microscopic lesions involving the 
gastrointestinal tract.  
The group of dogs with CIE included 22 client-owned dogs with samples 
retrieved from the archives of the Gastrointestinal Laboratory at Texas A&M University 
and the Faculty of Veterinary Medicine at University of Helsinki. The inclusion criteria 
included histological findings of inflammation in colonic biopsy specimens, persistent 
(>3 weeks’ duration) gastrointestinal signs, and failure to document other causes for 
gastroenteritis (e.g. infectious, parasitic, neoplastic) by thorough diagnostic testing. The 
diagnostic evaluation in all dogs with CIE consisted of a clinical examination and 
analysis of clinical history, hematological and serum biochemistry analysis, urinalysis, 
fecal examination, diagnostic imaging, and histopathological examination of mucosal 
biopsy specimens. The CIBDAI was determined at presentation by the attending 
veterinarian, according to the dog’s attitude/activity, appetite, vomiting, fecal 
consistency, defecation frequency, and weight loss; with the cumulative score ranging 
from 0-18.25 Most of the dogs with CIE (18/22) had not received antibiotics in the 4 
months before sample collection. Four dogs had received antibiotics 3-4 weeks prior 
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sample collection. None of the dogs were treated with immunosuppressive drugs before 
sampling. Colonic samples used for FISH were collected via colonoscopy. In most dogs, 
the preparation for colonoscopy included feeding a low-residue diet (boiled cod fish or 
duck) for 4 days, fasting for 24 hours before the procedure, and an enema with 20 
mL/kg of warm water immediately before the procedure. Endoscopically obtained 
samples of colonic mucosa were fixed in 10% formalin, routinely processed for 
histopathology, and stained with hematoxylin and eosin. Histological changes in the 
colon were classified using a grading system for histopathologic criteria (0 = normal, 1 = 
mild lesions, 2 = moderate lesions, and 3 = severe lesions), which was developed by 
the World Small Animal Veterinary Association Gastrointestinal Standardization 
Group.2,13 Individual scores were assigned for each parameter (i.e., surface epithelial 
injury, crypt dilation, fibrosis, goblet cell count, and lamina propria infiltrate with 
lymphocytes/plasma cells, eosinophils, neutrophils, and/or macrophages, as individual 
cellular infiltrates).  
 
FISH and Bacterial Quantification 
The colonic samples were routinely processed for histology and 4 µm formalin-
fixed paraffin-embedded sections were used for FISH. After deparaffinization in xylene 
and hydration in ethanol, serial sections were individually hybridized with oligo probes 
diluted to 5 ng/µL in hybridization buffer. The probes (Table 1) targeting the 16S rRNA 
gene of bacteria included the universal bacterial probe EUB338 for total bacterial 
counts, and the specific probes for Helicobacter spp., Escherichia coli/Shigella spp., 
Faecalibacterium spp., and Akkermansia spp. Each intestinal section was also 
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separately hybridized with a negative control, non-sense probe (non-EUB-Alexa Fluor 
488) to evaluate possible bacterial autofluorescence.56 After hybridization, the slides 
were extensively washed in buffer, mounted with antifade solution containing 4′,6-
diamidino-2-phenylindole (DAPI), and analyzed using an epifluorescence microscope 
(Olympus BX43). For each case and each probe, 10 random fields with labeled bacteria 
on the surface above the epithelium and in 10 crypts were captured with a 40x and 60x 
objective, respectively. A minimum of 3 different endoscopic biopsies were evaluated for 
mucosal bacterial content. Each field was captured with the DAPI filter for identification 
of host cell nuclei, fluorescein isothiocyanate (FITC) filter for background 
autofluorescence from the host epithelium, and tetramethylrhodamine-isothiocyanate 
(TRITC) filter for identification of probe-labeled bacteria. The images from the three 
filters were combined before quantification. Due to the presence of areas with dense 
numbers of bacteria that often overlapped, bacterial quantification was performed using 
ImageJ software. Quantification was only performed when the hybridization signals 
were strong and orange to red with the combined filters. A positive hybridization signal 
was not observed using similar technical conditions with the non-EUB338 probe. The 
individual size of bacteria was established by measuring 20 individualized bacteria (with 
a 60x objective for the crypts and 40x for the surface) in each bacterial group and 
calculating the mean size. The number of pixels representing positive labeling was 
recorded for each of the captured fields using ImageJ software and the median number 





The datasets were tested for normality and equality of variances using a Shapiro Wilk’s 
test and the Brown-Forsythe test, respectively. The mean number of labeled bacteria 
per field for each probe and compartment in dogs with CIE and controls was compared 
using a Mann-Whitney U test or Student’s t test where appropriate. A Spearman’s rank 
correlation coefficient was calculated to test for possible correlations between the 
number and location of labeled bacteria, CIBDAI scores, individual and cumulative 
histopathological scores in dogs with CIE. Tests were performed on JMP software (JMP 




The CIE group was comprised of 22 dogs (12 males and 10 females; median 
age: 3.2 years; age range: 0.5 - 13 years). The most commonly represented breeds 
included German shepherd (n = 4), soft coated wheaten terrier (n = 2), and mixed breed 
dogs (n = 3). The median body weight was 23.9 kg (range: 5.5-43.4 kg). All dogs with 
CIE presented for variable and chronic gastrointestinal signs indicative of enterocolitis. 
The median CIBDAI score was 5 out of 18 (range: 2-9). Based on the CIBDAI scores, 
thirteen dogs with CIE had insignificant or mild disease activity (score: 2 - 5), 8 dogs 
had moderate disease activity (score: 6 - 8), and 1 dog had severe disease activity 
(score ≥ 9). When the histopathological scores for each morphologic parameter in the 




The control group was composed of 11 dogs (5 males and 6 females) and the 
median age was 4 years (age range: 1 - 13 years). The median body weight was 23.6 
kg (range: 2.7 - 32 kg). There was no history of gastrointestinal signs or abnormalities of 
the gross or histopathological analysis of the gastrointestinal tract (histopathological 
score = 0). The age (P = .44) and body weight (P = .95) of control dogs was not 
statistically different from dogs with CIE.  
 
Mucosal Microbiota 
All the bacterial groups investigated with FISH were located on the colonic 
surface and within the crypts in both control dogs and dogs with CIE (Figs. 1, 2 and 
Table 2, Table S1). The number of total bacteria labeled with EUB338 probe (P = .002) 
was decreased within the crypts of dogs with CIE (Figs. 3, 4) compared to control dogs. 
Dogs with CIE had higher numbers of Escherichia coli/Shigella on the colonic surface (P 
= .009) and within the crypts (P = .015) as compared to control dogs. Both Helicobacter 
spp. (Figs. 5, 6) and Akkermansia spp. (Figs. 7, 8) were decreased on the colonic 
surface (P = .03; P = .012, respectively) and in the crypts (P = .008; P = .0003, 
respectively) of dogs with CIE. No differences were detected in the number of 
Faecalibacterium spp. or the total number of bacteria on the colonic surface between 
control dogs and dogs with CIE. There were no statistical differences between the data 
of the four dogs with CIE that received antibiotics and the dogs with CIE that had not 





Spearman’s rank correlation coefficient showed no significant correlation 
between mucosal bacterial populations in the colon and the CIBDAI or histopathological 
scores (individual or cumulative) in dogs with CIE.  
 
Discussion 
In this study we demonstrated reduced numbers of total cryptal bacteria in the 
colon of dogs with CIE. Similar to our findings, a reduction in the cryptal bacteria has 
previously been described in the colon of humans with acute ulcerative colitis, although 
the bacterial species were not characterized.44 The cryptal microbiota is thought to play 
a role in mucosal homeostasis, promoting immunomodulation and serving as a reservoir 
for bacteria, allowing recolonization of the gut after disruption by antibiotics or 
infection.16 The predominance of a bacterial species in a specific niche is not an 
uncommon concept. In mice, the segmented filamentous bacterium dominates at the 
epithelial surface of the gut associated lymphoid tissue and Alcaligenes spp. is an 
almost-exclusive inhabitant of murine Peyer’s patches.35 In mice, the colonic crypts are 
known to be colonized by Acinetobacter spp.,37 Helicobacter spp.,58 and Bacteroides 
spp.43  
Helicobacter spp. was the predominant bacterial group colonizing the colonic 
crypts in the control dogs of our study. Helicobacter spp. was previously demonstrated 
to colonize the stomach and small intestine via adherence to epithelial surface 
glycans.27 Helicobacter spp. can be classified as enterohepatic or gastric.46 Gastric 
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strains are larger “corkscrew” spiral-shaped bacteria while enterohepatic strains are 
slightly curved to spindle-shaped with tapered ends.41 Helicobacter pylori is an 
important pathogen associated with the development of peptic and gastric ulceration as 
well as gastric cancer in humans.36 However, natural H. pylori infection has not been 
described in the dog, which harbors H. bizzozeronii and H. felis in the gastric mucosa.41 
Enterohepatic species of Helicobacter have previously been reported to be the main 
bacterial group colonizing the colonic crypts of healthy dogs.41 Helicobacter spp. DNA 
has previously been amplified from the colonic mucosa in all 6 of 6 healthy dogs 
tested.41 These cryptal bacteria have been described to belong to H. bilis/flexispira 
taxon 8, H. cinaedi, and H. canis, with different species colonizing the same individual.41 
Helicobacter spp. can be cultured from the feces of both healthy dogs and dogs with 
gastrointestinal disease with a similar prevalence.42 The significance of enterohepatic 
species of Helicobacter that colonize the intestinal tract and the liver of humans and 
animals is controversial.46 Because enterohepatic strains are highly prevalent in healthy 
humans and animals, they have been considered as members of the commensal 
bacterial microbiota.46 However, some studies have associated these bacteria with 
gastroenteritis, hepatitis, and other diseases.46 We considered Helicobacter spp. a 
commensal bacterium in control dogs, contrasting a previous study10 that described a 
positive association between mucosal fibrosis/atrophy and the abundance of 
Helicobacter spp. in the colonic crypts of dogs with gastrointestinal disease. The study 
by Castiglioni et al.10 analyzed samples from dogs with either acute or chronic 
gastrointestinal disease using immunohistochemistry, which is considered to be less 
specific than FISH. Their study did not include a control group and did not identify a 
13 
 
positive correlation between colonization by Helicobacter spp. and intestinal 
inflammation. Our results support a previous study that reported decreased numbers of 
Helicobacter spp. in the colonic mucosal surface of dogs with CIE.9 
The colonic mucus layer of humans is enriched in Akkermansia muciniphila, a 
mucin-utilizing, anaerobic, gram-negative bacterial species.7,14 A depletion of the 
mucosal population of Akkermansia muciniphila is a common finding in humans with 
inflammatory bowel disease,39,40 suggesting that it may have potential anti-inflammatory 
properties. Akkermansia muciniphila beneficially affects glucose metabolism, lipid 
metabolism, and intestinal immunity.18,38,48 Akkermansia spp., within the 
Verrucomicrobia phyla, is rarely identified in feces of dogs through next generation 
sequencing,51 probably because this bacterial species is present in low abundance and 
closely associated with the colonic mucus layer and crypts in dogs. Further studies are 
warranted to investigate the role of Akkermansia spp. in gastrointestinal health and 
disease in dogs. 
Human patients with inflammatory bowel disease have an increased abundance 
of bacteria at the inflamed colonic mucosal surface,52 including Bacteroides spp. and E. 
coli.6,32 Although the abundance of total bacteria on the colonic surface did not differ 
between control and CIE dogs, our findings support a previous study that described 
increased E. coli and Enterobacteriaceae bacteria within the colonic and ileal mucosa of 
dogs with CIE.9 Previous studies utilizing 16S rRNA sequencing and qPCR found that 
Faecalibacterium spp. bacteria were decreased in the feces of dogs with CIE,3,20 while 
we were unable to detect significant differences between control dogs and dogs with 
CIE in the mucosa. The lack of statistical correlation between mucosal bacterial 
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numbers and the CIBDAI or histopathology scores could be related to the marked 
individual variability in bacterial counts in dogs with CIE or due to the predominance of 
dogs with mild clinical disease. Although alterations in intestinal microbial composition 
have long been associated with chronic intestinal inflammation; it has been difficult to 
prove whether dysbiosis is a cause or effect of disease.34 
In this study, we used archived formalin-fixed samples from clinical cases to 
characterize the mucosal microbiota. Although Carnoy’s fixative can be superior to 
formalin in preserving the mucus layer,53 several studies have utilized formalin-fixed 
samples for quantification of bacteria in humans6,49,52 and animals9,24,26 and 
demonstrated a largely intact mucus layer. In control dogs, full-thickness samples were 
collected immediately after the dogs were euthanized for reasons unrelated to this 
study, to avoid the unnecessary use of animals for experiments. On the other hand, the 
colonic samples in dogs with CIE were collected endoscopically, with routine colonic 
cleansing prior to collection. It is possible that the cleansing might affect the mucosal 
biofilm. However, it seems unlikely that the cleansing would affect the deeper microbiota 
within the colonic crypts or alter the composition of specific bacterial groups. 
Additionally, the age, sex, breed, and diet can influence the gut microbiota. While very 
high protein diets (~45 g/100 g of dry matter) may affect the intestinal microbiota of 
dogs, such high levels of protein are not commonly found in commercial diets (~27 
g/100 g of dry matter).21,45,47 
Conclusions 
This study showed that dogs with CIE had alterations in the composition of their 
colonic mucosal microbiota. Interestingly, the cryptal bacteria that are intimately 
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associated with the host mucosa and composed mainly of Helicobacter spp., were 
depleted in dogs with CIE. Helicobacter alone, or associated with other bacterial 
species described here in lower abundance could play a role in excluding colonization 
by pathogenic bacteria or in regulating inflammation in the canine colon. Future 
immunologic and metagenomic studies are warranted to better understand the host–
microbiome interaction in canine CIE.  
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Figure Legends 
Figures 1-2. Diagrams representing the distribution and relative number of bacteria on 
the colonic surface and in the crypts of control dogs and dogs with chronic inflammatory 
enteropathy (CIE). Fig 1. Total bacteria. The number of total bacteria was decreased in 
the crypts of dogs with CIE compared to control dogs.  
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Figure 2. Different bacterial groups. Helicobacter spp. and Akkermansia spp. were 
decreased on the surface and within the crypts of the colon of dogs with CIE, compared 
to control dogs. Dogs with CIE had higher numbers of E. coli/Shigella on the surface 
and within the crypts compared to control dogs. The abundance of Faecalibacterium 
spp. did not differ between the two groups. 
Figures 3-8. Colon, dogs. Fluorescence in situ hybridization: red—bacteria; green—
autofluorescence of the intestinal mucosa and contents; blue—DAPI-stained nuclei of 
colonic mucosa. Figure 3. Control dog. Numerous bacteria are labeled with EUB338 
probe in a colonic crypt. Figure 4. Chronic inflammatory enteropathy. The colonic crypt 
contains only a single EUB338-labeled bacterium. Figure 5. Control dog. The colonic 
crypt contains abundant curved to spindle-shaped bacteria labeled with the Helicobacter 
spp. probe. Figure 6. Chronic inflammatory enteropathy. A single bacterium labeled 
with the Helicobacter spp. probe is in a colonic crypt. Figure 7. Control dog. The colonic 
surface mucus contains bacteria labeled with the Akkermansia spp. probe. Figure 8. 






















Table 1. Probes targeting bacterial 16S rRNA used for in situ hybridization 
Targeted bacteria 
(probe) 
Probe sequence (5’ – 3’)  Fluorophore Reference 
Eubacteria (EUB338) GCT GCC TCC CGT AGG AGT Cy 3 4 




































Table 2. Number of bacteria on the colonic surface and within crypts of dogs with chronic inflammatory enteropathy (CIE) 
and control dogs. The data are expressed as the median number of bacteria per field and the range, evaluated in ten 
400x magnification fields on the surface or in ten 600x magnification fields in the crypts. *P < .01, **P <.05. 
 









182 (6.98 - 6,258.70) 
 
0.12 (0 - 1.67)* 
 
0.73 (0.08 -166.03)** 
 
0.73 (0 - 48.07) 
 
0.21 (0 - 26.74)** 
Crypts 0.38 (0.03 - 80.45)* 0.01 (0 - 1.00)** 0.31 (0 - 1.00)** 0.07 (0 - 0.78) 0.11 (0 - 8.92)* 
Total 196.41 (7.75 - 6,339.18) 0.15 (0 - 1.97)** 1.04 (0.37 - 166.54)* 0.82 (0 - 48.07) 0.47 (0 - 31.20)* 
Control      
Surface 51.80 (14.55 - 687.00) 0.70 (0.03 - 78.02) 0.23 (0-1.49) 1.02 (0.1 - 66.20) 30.21 (0 - 191.50) 
Crypts 52.73 (0 - 225.10) 0.82 (0 - 27.84) 0.06 (0 - 0.58) 0.14 (0 - 11.55) 25.65 (0 - 85.74) 
Total 314.25 (15.04 - 794.20) 2.77 (0.16 – 84.09) 0.26 (0.04 – 1.85) 1.22 (0.19 - 78.75) 55.56 (0 - 230.56) 
